» Articles » PMID: 37903800

The Microprotein Encoded by Exosomal LncAKR1C2 Promotes Gastric Cancer Lymph Node Metastasis by Regulating Fatty Acid Metabolism

Overview
Journal Cell Death Dis
Date 2023 Oct 31
PMID 37903800
Authors
Affiliations
Soon will be listed here.
Abstract

Lymph node metastasis (LNM) is the prominent route of gastric cancer dissemination, and usually leads to tumor progression and a dismal prognosis of gastric cancer. Although exosomal lncRNAs have been reported to be involved in tumor development, whether secreted lncRNAs can encode peptides in recipient cells remains unknown. Here, we identified an exosomal lncRNA (lncAKR1C2) that was clinically correlated with lymph node metastasis in gastric cancer in a VEGFC-independent manner. Exo-lncAKR1C2 secreted from gastric cancer cells was demonstrated to enhance tube formation and migration of lymphatic endothelial cells, and facilitate lymphangiogenesis and lymphatic metastasis in vivo. By comparing the metabolic characteristics of LN metastases and primary focuses, we found that LN metastases of gastric cancer displayed higher lipid metabolic activity. Moreover, exo-lncAKR1C2 encodes a microprotein (pep-AKR1C2) in lymphatic endothelial cells and promotes CPT1A expression by regulating YAP phosphorylation, leading to enhanced fatty acid oxidation (FAO) and ATP production. These findings highlight a novel mechanism of LNM and suggest that the microprotein encoded by exosomal lncAKR1C2 serves as a therapeutic target for advanced gastric cancer.

Citing Articles

Lipid metabolic reprograming: the unsung hero in breast cancer progression and tumor microenvironment.

Wan M, Pan S, Shan B, Diao H, Jin H, Wang Z Mol Cancer. 2025; 24(1):61.

PMID: 40025508 PMC: 11874147. DOI: 10.1186/s12943-025-02258-1.


Noncoding RNA-encoded peptides in cancer: biological functions, posttranslational modifications and therapeutic potential.

Tan S, Yang W, Ren Z, Peng Q, Xu X, Jiang X J Hematol Oncol. 2025; 18(1):20.

PMID: 39972384 PMC: 11841355. DOI: 10.1186/s13045-025-01671-9.


Effects of microplastics on chemo-resistance and tumorigenesis of colorectal cancer.

Pan W, Han Y, Zhang M, Zhu K, Yang Z, Qiu M Apoptosis. 2025; .

PMID: 39924586 DOI: 10.1007/s10495-025-02085-1.


The Role of the CPT Family in Cancer: Searching for New Therapeutic Strategies.

Duan Y, Liu J, Li A, Liu C, Shu G, Yin G Biology (Basel). 2024; 13(11).

PMID: 39596847 PMC: 11592116. DOI: 10.3390/biology13110892.


Mesenchymal stem cell-derived exosomes in renal ischemia-reperfusion injury: a new therapeutic strategy.

Zhao B, Zhang Z, Guo X, Liu X, Lei M, Guo S Int Urol Nephrol. 2024; 57(3):875-884.

PMID: 39520637 DOI: 10.1007/s11255-024-04258-4.


References
1.
Gao J, Ao Y, Zhang L, Deng J, Wang S, Wang H . Exosomal circZNF451 restrains anti-PD1 treatment in lung adenocarcinoma via polarizing macrophages by complexing with TRIM56 and FXR1. J Exp Clin Cancer Res. 2022; 41(1):295. PMC: 9547453. DOI: 10.1186/s13046-022-02505-z. View

2.
Thery C, Zitvogel L, Amigorena S . Exosomes: composition, biogenesis and function. Nat Rev Immunol. 2002; 2(8):569-79. DOI: 10.1038/nri855. View

3.
Morton D, Thompson J, Cochran A, Mozzillo N, Elashoff R, Essner R . Sentinel-node biopsy or nodal observation in melanoma. N Engl J Med. 2006; 355(13):1307-17. DOI: 10.1056/NEJMoa060992. View

4.
Pirlog R, Calin G . KRAS mutations as essential promoters of lymphangiogenesis via extracellular vesicles in pancreatic cancer. J Clin Invest. 2022; 132(14). PMC: 9282924. DOI: 10.1172/JCI161454. View

5.
Chen C, He W, Huang J, Wang B, Li H, Cai Q . LNMAT1 promotes lymphatic metastasis of bladder cancer via CCL2 dependent macrophage recruitment. Nat Commun. 2018; 9(1):3826. PMC: 6148066. DOI: 10.1038/s41467-018-06152-x. View